Literature DB >> 20538331

Involvement of mast cells in eosinophilic esophagitis.

J Pablo Abonia1, Carine Blanchard, Bridget Buckmeier Butz, Heather F Rainey, Margaret H Collins, Keith Stringer, Philip E Putnam, Marc E Rothenberg.   

Abstract

BACKGROUND: Eosinophilic esophagitis (EE) is an emerging disorder with poorly understood pathogenesis.
OBJECTIVE: Whereas prior studies have primarily focused on the role of eosinophils in disease diagnosis and pathogenesis, this study investigates the involvement of mast cells.
METHODS: Total and degranulated mast cell counts were correlated to microarray and RT-PCR data to generate transcriptome expression profiles related to mast cell number and degranulation in patients with EE and healthy control subjects.
RESULTS: Esophageal mastocytosis and mast cell degranulation were readily apparent in patients with EE compared with control subjects (P < .01), as assessed by staining for total mast cells and the presence of extracellular mast cell tryptase (P < .01). Microarray analysis revealed that mast cell levels correlated with the dysregulation of 0.8% (301 genes) of the genome, which was partially distinct from the genes that correlated with tissue eosinophilia. The expression of transcripts for the mast cell proteases carboxypeptidase A3 and tryptase, but not chymase, correlated with mast cell levels and distinguished patients with EE from control subjects. Suprabasilar mast cell counts (P < .01) and degranulation (P < .01) were proportional with KIT ligand mRNA expression. Treatment of patients with EE with swallowed fluticasone propionate normalized levels of mast cells and the mast cell-related transcriptome in responder patients.
CONCLUSION: Herein we have identified local mastocytosis and mast cell degranulation in the esophagi of patients with EE; identified an esophageal mast cell-associated transcriptome that is significantly divergent from the eosinophil-associated transcriptome, with carboxypeptidase A3 mRNA levels serving as the best mast cell surrogate marker; and provided evidence for the involvement of KIT ligand in the pathogenesis of EE. Copyright 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538331      PMCID: PMC2902643          DOI: 10.1016/j.jaci.2010.04.009

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  63 in total

1.  Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis.

Authors:  Jonathan M Spergel; Terri Brown-Whitehorn; Janet L Beausoleil; Michele Shuker; Chris A Liacouras
Journal:  J Allergy Clin Immunol       Date:  2007-02       Impact factor: 10.793

2.  Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease.

Authors:  Richard Kirsch; Rana Bokhary; Margaret A Marcon; Ernest Cutz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-01       Impact factor: 2.839

3.  Esophageal remodeling in pediatric eosinophilic esophagitis.

Authors:  Seema S Aceves; Robert O Newbury; Ranjan Dohil; John F Bastian; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2007-01       Impact factor: 10.793

4.  Pediatric patients with eosinophilic esophagitis: an 8-year follow-up.

Authors:  Amal H Assa'ad; Philip E Putnam; Margaret H Collins; Rachel M Akers; Sean C Jameson; Cassie L Kirby; Bridget K Buckmeier; Jennifer Z Bullock; Ann R Collier; Michael R Konikoff; Richard J Noel; Jesus R Guajardo; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2007-01-25       Impact factor: 10.793

5.  Common variants at 5q22 associate with pediatric eosinophilic esophagitis.

Authors:  Marc E Rothenberg; Jonathan M Spergel; Joseph D Sherrill; Kiran Annaiah; Lisa J Martin; Antonella Cianferoni; Laura Gober; Cecilia Kim; Joseph Glessner; Edward Frackelton; Kelly Thomas; Carine Blanchard; Chris Liacouras; Ritu Verma; Seema Aceves; Margaret H Collins; Terri Brown-Whitehorn; Phil E Putnam; James P Franciosi; Rosetta M Chiavacci; Struan F A Grant; J Pablo Abonia; Patrick M A Sleiman; Hakon Hakonarson
Journal:  Nat Genet       Date:  2010-03-07       Impact factor: 38.330

6.  A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.

Authors:  Michael R Konikoff; Richard J Noel; Carine Blanchard; Cassie Kirby; Sean C Jameson; Bridget K Buckmeier; Rachel Akers; Mitchell B Cohen; Margaret H Collins; Amal H Assa'ad; Seema S Aceves; Philip E Putnam; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

7.  Eosinophilic esophagitis disease in children from West Virginia: a review of the last decade (1995-2004).

Authors:  Rupa Gill; Paul Durst; Mary Rewalt; Yoram Elitsur
Journal:  Am J Gastroenterol       Date:  2007-06-15       Impact factor: 10.864

8.  Esophageal subepithelial fibrosis in children with eosinophilic esophagitis.

Authors:  Mirna Chehade; Hugh A Sampson; Raffaella A Morotti; Margret S Magid
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-09       Impact factor: 2.839

9.  Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder.

Authors:  Seema S Aceves; Robert O Newbury; Ranjan Dohil; Jeffrey Schwimmer; John F Bastian
Journal:  J Clin Gastroenterol       Date:  2007-03       Impact factor: 3.062

10.  Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus.

Authors:  Alfredo J Lucendo; Marta Navarro; Carmen Comas; Juan M Pascual; Emilio Burgos; Luis Santamaría; Javier Larrauri
Journal:  Am J Surg Pathol       Date:  2007-04       Impact factor: 6.394

View more
  112 in total

1.  Characterization of Mast Cell Activation Syndrome.

Authors:  Lawrence B Afrin; Sally Self; Jeremiah Menk; John Lazarchick
Journal:  Am J Med Sci       Date:  2016-12-16       Impact factor: 2.378

Review 2.  Diagnosis and management of eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 11.382

Review 3.  The Immunologic Mechanisms of Eosinophilic Esophagitis.

Authors:  David A Hill; Jonathan M Spergel
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

4.  Accuracy of digital mRNA profiling of oesophageal biopsies as a novel diagnostic approach to eosinophilic oesophagitis.

Authors:  Edda Fiebiger; Samuel Nurko; Willem S Lexmond; Lan Hu; Michael Pardo; Nicole Heinz; Katharine Rooney; Jessica LaRosa; Eleonora Dehlink
Journal:  Clin Exp Allergy       Date:  2015-08       Impact factor: 5.018

Review 5.  Immunopathology of chronic rhinosinusitis.

Authors:  Atsushi Kato
Journal:  Allergol Int       Date:  2015-02-09       Impact factor: 5.836

Review 6.  Molecular, genetic, and cellular bases for treating eosinophilic esophagitis.

Authors:  Marc E Rothenberg
Journal:  Gastroenterology       Date:  2015-02-07       Impact factor: 22.682

7.  Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps.

Authors:  Tetsuji Takabayashi; Atsushi Kato; Anju T Peters; Lydia A Suh; Roderick Carter; James Norton; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Shigeharu Fujieda; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2012-04-24       Impact factor: 10.793

8.  Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease.

Authors:  Evan S Dellon; Xiaoxin Chen; C Ryan Miller; Karen J Fritchie; Tara C Rubinas; John T Woosley; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2010-10-26       Impact factor: 10.864

9.  Interleukin 9 Alters Epithelial Barrier and E-cadherin in Eosinophilic Esophagitis.

Authors:  Ashmi Doshi; Rebecca Khamishon; Renee Rawson; Loan Duong; Lucas Dohil; Stephen J Myers; Braxton Bell; Ranjan Dohil; Robert O Newbury; Kim E Barrett; Richard C Kurten; Seema S Aceves
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-02       Impact factor: 2.839

10.  Eosinophilic gastrointestinal diseases--clinically diverse and histopathologically confounding.

Authors:  Seema Aceves; Ikuo Hirano; Glenn T Furuta; Margaret H Collins
Journal:  Semin Immunopathol       Date:  2012-07-29       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.